{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:10:29Z","timestamp":1790169029572,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.healun.2021.08.010","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T14:30:22Z","timestamp":1630161022000},"page":"148-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3983-3195","authenticated-orcid":false,"given":"Yael","family":"Peled","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3292-821X","authenticated-orcid":false,"given":"Eilon","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3641-1114","authenticated-orcid":false,"given":"Jacob","family":"Lavee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Segev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomi","family":"Matezki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Wieder-Finesod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Mandelboim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Indenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4716-1293","authenticated-orcid":false,"given":"Itzchak","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Sternik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Raanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Afek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitshak","family":"Kreiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaniv","family":"Lustig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galia","family":"Rahav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2021.08.010_bib0001","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"mRNA-1273 Study Group. An mRNA vaccine against SARS-CoV-2\u2014preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.08.010_bib0002","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.healun.2021.04.003","article-title":"BNT162b2 vaccination in heart transplant recipients: clinical experience and antibody response","volume":"40","author":"Peled","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.08.010_bib0003","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.healun.2021.04.018","article-title":"COVID-19 vaccination immune paresis in heart and lung transplantation","volume":"40","author":"Aslam","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.08.010_bib0004","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1097\/TP.0000000000003836","article-title":"Development of COVID-19 infection in transplant recipients after SARS-CoV-2 vaccination","volume":"105","author":"Ali","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.08.010_bib0005","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.16618","article-title":"COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination","author":"Wadei","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2021.08.010_bib0006","article-title":"Convergent epitope-specific T cell responses after SARS-CoV-2 infection and vaccination","author":"Minervina","year":"2021","journal-title":"posted medRxiv"},{"key":"10.1016\/j.healun.2021.08.010_bib0007","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJMc2108861","article-title":"Three doses of an mRNA Covid-19 Vaccine in solid-organ transplant recipients","volume":"385","author":"Kamar","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.08.010_bib0008","doi-asserted-by":"crossref","DOI":"10.7326\/L21-0282","article-title":"Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a case series","author":"Werbel","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.healun.2021.08.010_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.12339","article-title":"Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients with minimal serologic response to 2 doses","author":"Benotmane","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2021.08.010_bib0010","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2111462","article-title":"Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients","author":"Hall","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.08.010_bib0011","unstructured":"Available at SSRN: https:\/\/ishlt.org\/ishlt\/media\/documents\/ISHLT-AST_SARS-CoV-2-Vaccination_7-16-21.pdf"},{"key":"10.1016\/j.healun.2021.08.010_bib0012","doi-asserted-by":"crossref","first-page":"e13563","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidates and recipients: guidelines from the American Society of Transplantation Infectious Diseases community of practice","volume":"33","author":"Danziger-Isakov","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2021.08.010_bib0013","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.healun.2021.08.010_bib0014","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.healun.2017.06.009","article-title":"Metformin therapy reduces the risk of malignancy after heart transplantation","volume":"36","author":"Peled","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.08.010_bib0015","unstructured":"Available at SSRN:https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/pfizer-biontech-covid-19-vaccine."},{"key":"10.1016\/j.healun.2021.08.010_bib0016","article-title":"Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation","volume":"29","author":"Oved","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.healun.2021.08.010_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241164","article-title":"Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis","volume":"15","author":"Indenbaum","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2021.08.010_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.06.020","article-title":"A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition","volume":"28","author":"Dieterle","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.healun.2021.08.010_bib0019","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/s41467-021-22958-8","article-title":"Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival","volume":"12","author":"Dispinseri","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.healun.2021.08.010_bib0020","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1473-3099(21)00127-4","article-title":"Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials","volume":"21","author":"Yang","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.healun.2021.08.010_bib0021","doi-asserted-by":"crossref","unstructured":"Flaxman A, Marchevsky Jenkin D, et\u00a0al. The Oxford COVID vaccine, tolerability and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 (AZD1222). Accessed September 16, 2021. https:\/\/ssrn.com\/abstract=3873839","DOI":"10.2139\/ssrn.3873839"},{"key":"10.1016\/j.healun.2021.08.010_bib0022","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.healun.2021.08.010_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/0264-410X(96)00062-X","article-title":"Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination","volume":"14","author":"West","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.healun.2021.08.010_bib0024","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/eji.1830161018","article-title":"Distinct short-lived and long-lived antibody-producing cell populations","volume":"16","author":"Ho","year":"1986","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.healun.2021.08.010_bib0025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/346749a0","article-title":"Maintenance of B-cell memory by long-lived cells generated from proliferating precursors","volume":"346","author":"Schittek","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.healun.2021.08.010_bib0026","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0264-410X(99)00012-2","article-title":"Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose","volume":"17","author":"Wistr\u00f6m","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.healun.2021.08.010_bib0027","doi-asserted-by":"crossref","first-page":"286.e7","DOI":"10.1016\/j.cmi.2020.09.051","article-title":"A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients","volume":"27","author":"Petrone","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.healun.2021.08.010_bib0028","doi-asserted-by":"crossref","unstructured":"Mateus J, Dan JM, Zhang Z, et al. Low dose mRNA-1273 COVID-19 vaccine generates durable T cell memory and antibodies enhanced by pre-existing crossreactive T cell memory. medRxiv 2021.06.30.21259787; https:\/\/doi.org\/10.1101\/2021.06.30.21259787","DOI":"10.1101\/2021.06.30.21259787"},{"key":"10.1016\/j.healun.2021.08.010_bib0029","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant","volume":"385","author":"Lopez Bernal","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.08.010_bib0030","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMc2107799","article-title":"Infection and vaccine-induced neutralizing-antibody responses to the SARS-CoV-2 B.1.617 variants","volume":"385","author":"Edara","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.08.010_bib0031","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/jix257","article-title":"Serum C-reactive protein and congestive heart failure as significant predictors of herpes zoster vaccine response in elderly nursing home residents","volume":"216","author":"Verschoor","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.healun.2021.08.010_bib0032","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.healun.2021.05.004","article-title":"Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients","volume":"40","author":"Havlin","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.08.010_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.612747","article-title":"Optimize prime\/boost vaccine strategies: Trained immunity as a new player in the game","volume":"12","author":"Palgen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.healun.2021.08.010_bib0034","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1056\/NEJMc2110716","article-title":"Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination","volume":"385","author":"Normark","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.08.010_bib0035","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/s41591-021-01464-w","article-title":"Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19\/mRNA vaccination","volume":"27","author":"Schmidt","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.healun.2021.08.010_bib0036","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1080\/22221751.2021.1957401","article-title":"Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine","volume":"10","author":"Zhang","year":"2021","journal-title":"Emerg Microbes Infect"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821024815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821024815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:43:21Z","timestamp":1760949801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249821024815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1053249821024815"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2021.08.010","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2021.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}